Literature DB >> 31181202

Cardiopulmonary Testing Before Lung Resection: What Are Thoracic Surgeons Doing?

James M Clark1, Angelica S Marrufo1, Benjamin D Kozower2, Daniel J Tancredi3, Miriam Nuño4, David T Cooke5, Brad H Pollock6, Patrick S Romano7, Lisa M Brown8.   

Abstract

BACKGROUND: Cardiopulmonary assessment for lung resection is important for risk stratification, and the American College of Chest Physicians (ACCP) guidelines provide decision support. We ascertained the cardiopulmonary assessment practices of thoracic surgeons and determined whether they are guideline concordant.
METHODS: An anonymous survey was emailed to 846 thoracic surgeons who participate in The Society of Thoracic Surgeons General Thoracic Surgery Database. We analyzed survey responses by practice type (general thoracic [GT] versus cardiothoracic [CT]) and years in practice (0-9, 10-19, and ≥20) with the use of contingency tables. We compared adherence of survey responses with the guidelines.
RESULTS: The response rate was 24.0% (n = 203). Most surgeons (n = 121, 59.6%) cited a predicted postoperative forced expiratory volume in 1 second or diffusing capacity of lung for carbon monoxide threshold of 40% for further evaluation. Experienced surgeons (≥20 years) were more likely to have a threshold that varies by surgical approach (31.3% versus 23.5% with 10-19 years of experience and 15.9% for 0-9 years of experience, P = .007). Overall, 52.2% refer patients with cardiovascular risk factors to cardiology and 42.9% refer patients with abnormal stress testing. CT surgeons were more likely to refer all patients to cardiology than GT surgeons (17.6% versus 2.4%, P < .001). Only one respondent (0.5%) was 100% adherent to the ACCP guidelines, and 4.4% and 45.8% were 75% and 50% adherent, respectively.
CONCLUSIONS: Among thoracic surgeons, there is variation in preoperative cardiopulmonary assessment practices, with differences by practice type and years in practice, and marked discordance with the ACCP guidelines. Further study of guideline adherence linked to postoperative morbidity and mortality is warranted to determine whether adherence affects outcomes.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31181202     DOI: 10.1016/j.athoracsur.2019.04.057

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Evaluation of the 3-minute chair rise test as part of preoperative evaluation for patients with non-small cell lung cancer.

Authors:  Mathilde Azzi; David Debeaumont; Tristan Bonnevie; Bernard Aguilaniu; Damiano Cerasuolo; Fairuz Boujibar; Antoine Cuvelier; Francis-Edouard Gravier
Journal:  Thorac Cancer       Date:  2020-07-08       Impact factor: 3.500

2.  Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice?

Authors:  Mohammad R Ghamati; Wilson W L Li; Erik H F M van der Heijden; Ad F T M Verhagen; Ronald A Damhuis
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 3.005

3.  Self-reported exercise capacity among current smokers eligible for lung cancer screening: Distribution and association with key comorbidities.

Authors:  Anne C Melzer; Abbie Begnaud; Bruce R Lindgren; Kelsey Schertz; Steven S Fu; David M Vock; Alexander J Rothman; Anne M Joseph
Journal:  Cancer Treat Res Commun       Date:  2021-07-31

4.  Preoperative assessment for minimally invasive lung surgery: Need an update?

Authors:  Fairuz Boujibar; Francis-Edouard Gravier; Jean Selim; Jean-Marc Baste
Journal:  Thorac Cancer       Date:  2020-11-19       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.